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Detection of ischemic penumbra using combined perfusion and T2* oxygen
challenge imaging
Craig A. Robertson1†, Christopher McCabe1, M. Rosario Lopez-Gonzalez1,2,
Graeme A. Deuchar1, Krishna Dani1,2, William M. Holmes1, Keith W. Muir1,2,
Celestine Santosh2, I. Mhairi Macrae1*
Background Acute ischemic stroke is common and disabling,
but there remains a paucity of acute treatment options and
available treatment (thrombolysis) is underutilized. Advanced
brain imaging, designed to identify viable hypoperfused tissue
(penumbra), could target treatment to a wider population.
Existing magnetic resonance imaging and computed
tomography-based technologies are not widely used pending
validation in ongoing clinical trials. T2* oxygen challenge mag-
netic resonance imaging, by providing a more direct readout of
tissue viability, has the potential to identify more patients
likely to benefit from thrombolysis – irrespective of time from
stroke onset – and patients within and beyond the 4·5 h
thrombolysis treatment window who are unlikely to benefit
and are at an increased risk of hemorrhage.
Aims This study employs serial multimodal imaging and voxel-
based analysis to develop optimal data processing for T2*
oxygen challenge penumbra assessment. Tissue in the isch-
emic hemisphere is compartmentalized into penumbra, isch-
emic core, or normal using T2* oxygen challenge (single
threshold) or T2* oxygen challenge plus cerebral blood flow
(dual threshold) data. Penumbra defined by perfusion
imaging/apparent diffusion coefficient mismatch (dual thresh-
old) is included for comparison.
Methods Permanent middle cerebral artery occlusion was
induced in male Sprague-Dawley rats (n = 6) prior to serial
multimodal imaging: T2* oxygen challenge, diffusion-
weighted and perfusion imaging (cerebral blood flow using
arterial spin labeling).
Results Across the different methods evaluated, T2* oxygen
challenge combined with perfusion imaging most closely pre-
dicted 24 h infarct volume. Penumbra volume declined from
one to four-hours post-stroke: mean ± SD, 77 ± 44 to
49 ± 37 mm3 (single T2* oxygen challenge-based threshold);
55 ± 41 to 37 ± 12 mm3 (dual T2* oxygen challenge/cerebral
blood flow); 84 ± 64 to 42 ± 18 mm3 (dual cerebral blood flow/
apparent diffusion coefficient), as ischemic core grew: 155 ± 37
to 211 ± 36 mm3 (single apparent diffusion coefficient thresh-
old); 178 ± 56 to 205 ± 33 mm3 (dual T2* oxygen challenge/
cerebral blood flow); 139 ± 30 to 168 ± 38 mm3 (dual cerebral
blood flow/apparent diffusion coefficient). There was evi-
dence of further lesion growth beyond four-hours (T2-defined
edema-corrected infarct, 231 ± 19 mm3).
Conclusions In conclusion, T2* oxygen challenge combined
with perfusion imaging has advantages over alternative mag-
netic resonance imaging techniques for penumbra detection
by providing serial assessment of available penumbra based
on tissue viability.
Key words: ischemic penumbra, neuroimaging, oxygen challenge, T2*
MRI
Introduction
Following an acute ischemic stroke, the ischemic penumbra rep-
resents electrically inactive and metabolically compromised but
potentially viable tissue which is the target for acute stroke thera-
pies. It ultimately becomes incorporated into final infarct unless
salvaged by reperfusion. The thrombolytic agent alteplase
(recombinant tissue plasminogen activator, rt-PA) is the only
drug currently licensed to treat stroke. It may be administered
within 4·5 h of stroke onset based on clinical symptoms and a
noncontrast computed tomography (CT) scan to exclude intrac-
erebral hemorrhage or major established hypodensity (1).
Alteplase is designed to induce reperfusion by lysing occluding
blood clots and significantly increases independent recovery, but
carries a risk of brain hemorrhage (∼2%, increasing with delay in
administration) and is underutilized. A UK report of thromboly-
sis rates reported that an overall 1·4% of acute stroke patients
were thrombolysed, despite 14% of patients being eligible for
thrombolysis (2).
Thrombolysis decisions may soon be informed by more
advanced imaging, identifying a potential responder population
based on individual pathophysiology. Magnetic resonance
imaging (MRI) perfusion imaging (PI)/diffusion-weighted
imaging (DWI) mismatch is widely accepted as a marker of pen-
umbral tissue, while DWI/FLAIR mismatch may have utility in
predicting lesion age and is under investigation as a selection
marker for thrombolysis when stroke onset time is unknown
(3,4). Clinical adoption of perfusion/diffusion mismatch is cur-
rently limited by the lack of standardized perfusion and diffusion
thresholds, uncertain ability to differentiate penumbra from
benign oligemia, and uncertainty whether DWI hyperintensity
reflects irreversible damage, particularly at early time-points.
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Clinical trials have to date failed to support the utility of
perfusion–diffusion mismatch in selection for thrombolysis (5,6).
Alternative MRI techniques for penumbra detection are therefore
worthy of investigation, particularly methods that may offer an
index of tissue viability that is not dependent on interpretation of
PI thresholds alone.
We have developed such an alternative approach for penumbra
detection. T2* oxygen challenge (T2*OC) detects compensatory
mechanisms in response to reduced cerebral blood flow (CBF),
which may identify a distinct MRI tissue signature of penumbra.
Penumbra displays a higher venous deoxyhemoglobin concentra-
tion than surrounding tissue due to increased oxygen extraction
fraction (OEF) (7) and cerebral blood volume (CBV) (8). T2*
MRI is sensitive to OEF and CBV changes as venous deoxyhemo-
globin provides the contrast for blood oxygen level-dependent
(BOLD) T2* imaging (9). T2*OC uses a transient hyperoxic chal-
lenge to identify different tissue compartments in the ischemic
hemisphere, based on changes in deoxyhemoglobin : oxyhemo-
globin ratio (10). Deoxyhemoglobin and free oxygen dissolved in
plasma are paramagnetic and will reduce T2* signal, while dia-
magnetic oxyhemoglobin has minimal influence on T2*.
Increased oxygen delivery during an OC converts deoxyhemoglo-
bin to oxyhemoglobin, with a resultant increase in T2*-weighted
signal which can be mapped as a percentage signal change
(Fig. 1). Penumbra (and large veins) therefore displays the great-
est increase in T2*-weighted signal during an OC, ischemic core
displays the smallest change, and nonischemic tissue displays a
small increase in signal.
T2*OC may provide insight into the dynamic behavior of
hypoperfused tissue, and better prediction of tissue viability com-
pared with the PI/DWI paradigm. A small proof of concept study
in acute stroke patients (11) supports its potential clinical utility,
and subsequent preclinical developments have improved tech-
nique sensitivity and ability to translate to the clinic (12).
Aims
Compartmentalizing penumbra using two parameters (dual
threshold analysis combining T2*OC with CBF values) rather
than using a single T2* threshold may improve the technique
further and provide a more accurate assessment of penumbra. We
sought to compare single- and dual-threshold analysis for pen-
umbra quantification using T2*OC and to evaluate its utility for
serial scanning to track penumbra fate over the first four-hours in
a rat permanent middle cerebral artery occlusion (MCAO)
model. Serial PI and DWI (zero to four-hours), and 24 h
T2-weighted imaging provided information on ischemia, acute
tissue injury, and infarct, respectively, and alternative assessments
of penumbra from PI/apparent diffusion coefficient (ADC) mis-
match and ADC lesion growth.
Fig. 1 Multimodal MRI for one coronal slice in a representative rat and timeline of experimental protocol. Scanning commenced at approximately 1, 2·5,
4 and 24 h post-stroke: DWI to generate ADC maps, arterial spin labeling (ASL) to generate fully quantitative blood flow maps and mismatch images,
a T2*OC scan to derive T2* percentage signal change maps, and a RARE T2 map to identify 24 h infarct. Red arrows on the timeline depict blood gas
measurement 10 min before each OC scan. ADC, apparent diffusion coefficient; CBF, cerebral blood flow; DWI, diffusion weighted imaging; OC, oxygen
challenge; MCAO, middle cerebral artery occlusion; MRI, magnetic resonance imaging; PI, perfusion imaging.
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Methods
All experiments were performed under a UK Home Office license,
were subject to the Animals (Scientific Procedures) Act (1986)
and approved by the local University Ethical Review Panel.
Figure 1 displays the full experimental protocol.
Rodent MCAO surgery
Anesthesia was induced in male Sprague-Dawley rats (n = 6, 290–
350 g, Harlan, Bicester, UK) with 5% isoflurane and maintained
at 2% in medical air, enriched with oxygen (30%).
Body temperature was maintained at 37°C ± 0·5°C and a
femoral artery cannulated for continuous blood pressure moni-
toring (AcqKnowledge, Biopac Systems, Goleta, CA, USA) and
blood gas analysis. Permanent MCAO (pMCAO) was achieved
with a 5-0 silicon rubber-coated intraluminal monofilament
advanced to block the origin of the middle cerebral artery (13).
MRI scanning
MRI data were acquired on a Bruker Biospec (Wikingerstrasse,
Karlsruhe, Germany) 7-T/30-cm system equipped with an
inserted gradient coil (121 mm ID, 400 mT/m) and a 72-mm
birdcage resonator.
T2*-weighted imaging
A single-shot, gradient echo EPI sequence (TE: 20 ms, TR: 10 s,
matrix 96 × 96, FOV 25 × 25 mm, 8 contiguous slices of 1·5 mm
thickness, 2 averages, temporal resolution 20 s, 30 repetitions) was
used to assess T2*-weighted signal change during OC. The para-
digm for the T2*-weighted OC sequence was five-minutes
breathing air, followed by five-minutes breathing 100% oxygen,
and then 10 mins breathing air. Four coronal MRI slices through-
out MCA territory, selected to minimize the effect of susceptibil-
ity distortion around the ear canals, were used to generate
T2*-weighted signal change maps using ImageJ (http://
rsb.info.nih.gov/ij/). The average baseline signal (over five-
minutes) was subtracted from the peak signal during OC, then
divided by the average baseline signal and multiplied by 100.
DWI and PI scanning
DWI [spin-echo planar (SE-EPI) TE: 43 ms, TR: 4000·3 ms,
matrix 96 × 96, FOV 25 × 25 mm2, 3 directions: x, y, z, B values: 0,
1000 s/mm2, 8 slices of 1·5 mm thickness] was performed to
assess ischemically injured tissue and it was possible to collect
data from eight slices, four of which anatomically matched PI and
T2*. Noninvasive quantitative CBF was carried out to identify the
perfusion deficit on four 1·5-mm thick coronal slices throughout
the MCA territory using a form of pseudo-continuous arterial
spin labeling based on a train of adiabatic inversion pulses
(14,15). The sequence employs a spin-echo EPI imaging module
(TE 20 ms, TR 7000 ms, matrix 96 × 96, FOV 25 × 25 mm, slice
thickness 1·5 mm, 16 averages, 4 shots) preceded by 50 hyperbolic
secant inversion pulses in a 3s train.
T2-weighted imaging
A coronal RARE T2 sequence (effective TE: 46·8 ms, TR: 5000 s;
in plane resolution 97 μm; 30 slices, 0·75 mm thickness) was used
for T2-derived infarct measurement at 24 h post-stroke.
MRI data analysis for penumbra assessment
Volumes of tissue with abnormal T2*OC response were deter-
mined using two approaches: (1) applying a single threshold
[mean plus 2 standard deviations (SDs) of the contralateral hemi-
sphere, excluding the ventricles, venous sinuses, and large veins]
to T2*OC maps in ImageJ to derive tissue volumes (8,16);
(2) voxel-based analysis using T2* and CBF data and thresholds
to categorize tissue into four compartments (T2*OC-defined
penumbra, ischemic core, normal tissue and veins/venous
sinuses, see Fig. 3a). PI and DWI data were analyzed in two ways,
(1) voxel-based analysis using ADC and CBF thresholds to cat-
egorize tissue into five compartments: PI/ADC mismatch, isch-
emic core, normal, negative mismatch, and ventricles; and (ii)
penumbra volume derived from ADC lesion growth using an
in-house absolute ADC threshold.
Quantitative ADC maps (in mm2/s) were calculated using Para-
vision (Bruker BioSpin, Ettlingen, Germany) and subsequently
analyzed using ImageJ. CBF maps were also generated using
ImageJ. The ADC lesion was thresholded using an in-house abso-
lute ADC value of 0·59 × 10−3 mm2/s, which when applied to data
at four-hours post-stroke generated an ADC lesion which
matched 24 h (brain swelling corrected) infarct following perma-
nent MCAO in Sprague-Dawley rats.
Coregistration
T2* images were linearly coregistered to corresponding ADC slice
maps using Analyze (AnalyzeDirect, Inc., Overland Park, KS,
USA). Following coregistration, T2*, ADC and CBF thresholds
were applied to relevant images (four coronal slices within MCA
territory) for voxel-based analysis and volumetric measurements
of tissue compartments.
Voxel-based analysis
Voxel-based analysis, generated using codes written in Matlab
(MathWorks, Natick, MA, USA) allowed unbiased analysis of the
spatial, volumetric, and dynamic evolution of penumbra and
ischemic core. Tissue was compartmentalized using thresholds set
for two parameters: (1) T2* signal change and CBF for T2*OC
data sets; and (2) ADC and CBF data sets for PI/ADC mismatch.
Color-coded images were derived based on T2*OC signal change
and CBF values, or ADC and CBF values enabling analysis of
temporal changes in voxel distribution across ischemic core, pen-
umbra, and nonischemic tissue.
The number of voxels within each tissue compartment was
counted and converted to an area by multiplying the number of
pixels by the pixel area (0·0678 mm2) and then a volume by mul-
tiplying the areas by slice thickness (1·5 mm) and adding the
volumes for the four consecutive slices. Group data were gener-
ated for each tissue compartment at each acute time-point post-
stroke for T2*and CBF, ADC/CBF, and from the single T2*
threshold data sets.
Large veins and venous sinuses were segregated from the main
tissue compartments by excluding tissue with elevated T2*
(>mean + 2 SD of contralateral hemisphere) and CBF (values
above threshold – 57% reduction of mean contralateral CBF).
Ventricles were excluded from the ADC/CBF data sets by applying
an ADC threshold value (0·96 × 10−3 mm2/sec).
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For T2*OC/CBF analysis, the four compartments were:
• T2*OC-defined penumbra: T2* signal change above set thresh-
old, CBF value below set threshold
• Ischemic core: T2* signal change below set threshold, CBF
below set threshold
• Normal: T2* signal change below and CBF above set thresh-
olds, and
• Veins and venous sinuses: both T2* signal change and CBF
above set thresholds
For ADC/CBF analysis, the five compartments were:
• PI/ADC mismatch: ADC value above set threshold, CBF value
below set threshold
• Ischemic core: both ADC and CBF values below set thresholds
• Normal: both ADC and CBF values above set thresholds
• Negative mismatch: ADC value below threshold, CBF value
above threshold, and
• Ventricles: Above an ADC threshold of 0·96 × 10−3 mm2/s
ADC lesion expansion
ADC lesion expansion from one to four-hours was subtracted
from 24 h infarct data to provide an alternative assessment of
penumbra.
ADC lesion expansion
The absolute ADC threshold of 0·59 × 10−3 mm2/s was applied,
and the volume of the ADC lesion quantified by multiplying the
area on each slice by 1·5 (slice thickness) and summing the data
for either four or eight slices. Penumbral volume was derived by
subtracting the ADC lesion volume at each time-point from the
swelling-corrected 24 h infarct volume and was quantified over
four slices, for direct comparison with T2*OC and PI/ADC mis-
match and for all eight slices available from DWI.
Quantifying infarct volume at 24 h
Infarct was calculated from regions of hyperintensity on the
RARE T2 scans and corrected for ipsilateral brain swelling and
contralateral compression (17). Eight coronal RARE T2 slices
which matched the four-hour acute ADC slices were selected, and
the ipsilateral and contralateral hemisphere areas, as well as 24 h
infarct areas, were calculated by manual tracing using ImageJ. The
volumes of the ipsilateral and contralateral hemispheres and the
infarct were calculated by summing the individual areas and mul-
tiplying by slice thickness (0·75 mm).
Prediction error
Ischemic core and penumbra volumes were summed and sub-
tracted from edema-corrected infarct to calculate a prediction
error for each method.
Statistical analysis
Data are presented as mean ± SD. Comparison of physiological
variables, lesion evolution, and volumetric differences in isch-
emic core and penumbra across the four methods were
analyzed using one-way ANOVA with Student’s paired t-test and
Bonferroni correction. A paired t-test was used to analyze ADC-
derived lesion volume at four-hours and T2-defined infarct at
24 h.
Fig. 2 T2*OC percentage signal change maps and equivalent ADC maps over four coronal slices at 1, 2·5, and 4 h post-stroke in a representative animal.
T2*OC maps show a reduction in penumbral tissue from one to four-hours post-stroke, and ADC maps display a concomitant increase in ADC lesion.
Calibration bar on T2* maps, in units of percentage signal change and on ADC maps, in ×10−3 mm2/s. ADC, apparent diffusion coefficient; OC, oxygen
challenge.
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Results
Physiological variables
Physiological variables [apart from partial pressure of oxygen in
arterial blood (PaO2) during OCs] were maintained within physi-
ological limits. Recordings collected immediately before each OC
(Table 1) displayed no significant differences in partial pressure of
carbon dioxide in arterial blood (PaCO2) or PaO2. A small
increase in blood pH was recorded at four-hours compared with
one-hour and 2·5 h time-points (P < 0·0001).
(a)
(b)
Fig. 3 (a) Representative color-coded maps of T2*OC/CBF over four slices and three time-points post-stroke. Voxel-based analysis was performed by
applying the CBF (57% reduction in mean contralateral values) and T2* (mean + 2 SD) thresholds. There was an expansion in ischemic core with
concomitant loss of penumbral from one to four-hours post-stroke. Note that veins and venous sinuses (yellow shading) are differentiated from penumbral
tissue, due to high T2* value and CBF above thresholds. (b) Equivalent color-coded maps of PI/ADC mismatch in the same animal. Voxel-based analysis
performed using the same CBF threshold and an absolute ADC threshold of 0·6 × 10−3 mm2/s. ADC, apparent diffusion coefficient; CBF, cerebral blood
flow; OC, oxygen challenge; PI, perfusion imaging.
Table 1 Physiological variables
One-hour scan 2·5 h scan Four-hour scan
pH 7·34 ± 0·04 7·34 ± 0·05 7·36 ± 0·04*
PaCO2 44·5 ± 5·7 45·3 ± 10 42·4 ± 5·7
PaO2 93·6 ± 11 93·4 ± 12 95·7 ± 15
*P < 0·0001, one-way ANOVA followed by Student’s paired t-test
with a Bonferroni correction.
Physiological variables. Data from arterial blood samples collected
immediately before each OC. Data expressed as mean ± SD, n = 6.
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T2*OC -defined penumbra
Single threshold analysis
During OC, an increased T2* percentage signal change, compared
with surrounding and contralateral tissue, was apparent in dor-
solateral cortex (Fig. 1). This increased signal lay within the per-
fusion deficit adjacent to the diffusion abnormality (Figs 1 and 2).
The mean volume of tissue defined as penumbra was
77 ± 44 mm3 at one-hour post-stroke and gradually declined over
subsequent time-points (Table 2) as the volume of ADC-defined
core increased. OC repeated at 24 h revealed no increased T2*
signal in tissue previously identified as penumbra (Fig. 1,
Table 2).
Dual threshold analysis
Combining T2*% signal change and CBF data, voxels defining
penumbra were clustered in the dorsolateral cortex, with the
remaining voxels categorized as ischemic core, normal, or venous
sinuses/veins (Fig. 3a). Volumetric data for penumbra and isch-
emic core at three time-points are shown in Table 2. Normal and
venous compartments remained stable throughout (data not
shown).
PI/ADC mismatch-defined penumbra
Dual threshold voxel-based analysis
Equivalent ADC/CBF maps revealed a similar pattern of penum-
bra, ischemic core, and normal voxels (Fig. 3b). The fourth com-
partment (CBF above threshold, ADC below threshold) defined a
small number of negative mismatch voxels. Volumetric data for
penumbra and ischemic core are shown in Table 2. Normal and
negative mismatch compartments remained stable throughout
(data not shown).
ADC lesion growth-defined penumbra
Penumbra defined by subtracting the initial ADC lesion (over the
same four slices) from the 24-h T2-defined (edema-corrected)
infarct is presented in Table 2 for comparison. ADC data were also
available across a greater rostro-caudal range (eight coronal
slices). Penumbral volume determined from ADC lesion growth
across eight slices was 168 ± 59 mm3 at one-hour, 119 ± 50 mm3
at 2·5 h, and 92 ± 48 mm3 at four-hours post-stroke.
Comparison of methods for penumbra and ischemic
core detection
Volumetric (Table 2) and spatial differences (Fig. 3) in tissue
compartments were apparent between T2*OC/CBF and PI/ADC
mismatch-defined penumbra, although differences across the
four methods were not statistically significant. At one-hour post-
stroke, for penumbra volume determined from T2*OC/CBF, 69%
of voxels were also determined to be penumbra on PI/ADC mis-
match, and for penumbra volume determined from PI/ADC mis-
match, 44% of voxels were also determined to be penumbra on
T2*OC/CBF. The equivalent figures were 59% and 55%, respec-
tively, at 2·5 h, and 47% and 30%, respectively, at four-hours
post-stroke.
The sum of penumbra and ischemic core volumes, for the
different methods, was compared with (edema-corrected) infarct
volume to assess their predictive value (Fig. 4). Dual threshold
T2*/CBF produced the smallest prediction error at all three time-
points. All four methods provide evidence of remaining penum-
bra at the four-hour time-point. Four-hour ADC lesions
compared with 24 h T2-defined infarct revealed evidence for
further lesion growth beyond four-hours (Figs 5 and 6).
Discussion
Positive identification of penumbra is not employed in the
current imaging selection for intravenous rt-PA administration,
Fig. 4 Prediction error for different methods of penumbra and ischemic
core analysis. Penumbra and ischemic core volumes, calculated using each
of the three methods (dual ADC/CBF, single T2*OC + ADC lesion, and
dual T2*OC/CBF), were added together and subtracted from 24 h
(edema-corrected) infarct volume to generate prediction errors
(mean ± SD, n = 5). ADC, apparent diffusion coefficient; CBF, cerebral
blood flow; OC, oxygen challenge.
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which is based on exclusion of intracerebral hemorrhage or exten-
sive established ischemic damage on noncontrast CT. While
several observational clinical studies support perfusion/diffusion
mismatch as a penumbral marker that may identify a ‘responder’
population, both within three-hours of onset and at times up to
nine-hours after onset (18,19), a differential treatment effect in
imaging-selected patients is not yet supported by randomized
controlled trial data (6,20). PI/DWI mismatch is limited by the
lack of standardized perfusion and diffusion thresholds (21,22)
and small size of clinical data sets from which thresholds are
derived. Assumptions that underlie the interpretation of DWI-
and PW-abnormal tissue are questioned by findings including the
reversibility of some DWI lesions with early reperfusion (23) and
a heterogeneous metabolic state on concurrent positron emission
tomography (PET) from voxels within acute DWI lesions (24). A
fundamental limitation of current MR penumbral imaging is the
inability to detect metabolic activity. By offering a dynamic
measure of deoxyhemoglobin concentration that reflects varia-
tions in OEF (therefore, tissue metabolic capacity) and CBV, the
T2*OC technique may better discriminate penumbra, healthy
Table 2 Volumetric assessment of ischemic penumbra and ischemic core
one-hour post-stroke 2·5 h post-stroke Four-hours post-stroke 24 h post-stroke
Penumbra (mm3, n = 6)
Using single (T2*) threshold 77 ± 44 56 ± 38 49 ± 37 0
(range: 34–140) (range: 15–110) (range: 12–114)
Using dual (T2*/CBF) thresholds 55 ± 41 39 ± 22 37 ± 12 0
(range: 14–131) (range: 4–76) (range: 3–73)
PI/ADC mismatch 84 ± 64 52 ± 41 42 ± 18 0
Using dual (CBF/ADC) thresholds (range: 40–209) (range: 19–129) (range: 18–72)
Derived from ADC lesion growth 78 ± 37 43 ± 34 26 ± 29 0
(range: 35–117) (range: 0·41–84) (range: 13–83)
Ischemic core (mm3, n = 6)
Using single (ADC) threshold 155 ± 37 195 ± 44 211 ± 36 N/A
(range: 99–201) (range: 134–227) (range: 164–251)
Using dual (T2*/CBF) thresholds 178 ± 30 184 ± 41 205 ± 33 N/A
(range: 109–211) (range: 143–218) (range: 162–248)
Using dual (CBF/ADC) thresholds 139 ± 30 155 ± 32 168 ± 38 N/A
(range: 96–168) (range: 118–199) (range: 119–212)
24-h infarct, corrected for brain swelling (n = 5) N/A N/A N/A 231 ± 19
(range: 205–249)
Volumetric assessment (calculated over four coronal slices) of ischemic penumbra using the single T2* threshold and dual (T2*/CBF and CBF/ADC)
thresholds; ischemic core using the single ADC threshold, and dual (T2*/CBF and CBF/ADC) thresholds; 24-h edema-corrected infarct. One-way
ANOVA followed by Student’s paired t-test with Bonferroni correction. There was no statistically significant difference between penumbral volumes
assessed by the four different methods at any time-point. ADC, apparent diffusion coefficient; CBF, cerebral blood flow; PI, perfusion imaging.
Fig. 5 (a) ADC lesion areas at the three acute time-points and 24 h RARE T2-edema corrected infarct displayed across all eight forebrain slices and
presented as mean ± SD. ADC lesion expansion (and concomitant mismatch loss) over the first four-hours was greatest within the four central coronal
slices (3–6). Subsequent increases in ischemic damage were greatest in the caudal (1–3) and rostral (8) poles. ADC lesion volume increased significantly
over time (P < 0·05, one-way ANOVA with Bonferroni correction). (b) Equivalent ADC-derived lesion volume and T2-derived infarct volume at 4 h and
24 h, respectively (P < 0·001, Student’s paired t-test). The ADC lesion volume calculated over eight slices at 1, 2·5, and 4 h was 191 ± 51 mm3,
249 ± 51 mm3, and 356 ± 16 mm3, respectively (one to four-hours, P < 0·05). ADC, apparent diffusion coefficient.
ResearchC. A. Robertson et al.
© 2014 The Authors.
International Journal of Stroke published by John Wiley & Sons Ltd on behalf of World Stroke Organization
Vol ••, •• 2014, ••–•• 7
tissue, and ischemic core compared with existing MRI mismatch
techniques.
This study provides evidence for the utility of T2*OC serial
imaging in preclinical acute stroke research, and improved
predictive value when T2*OC is combined with CBF data using
voxel-based analysis. The maintenance of the increased T2* signal
during OC and its return to baseline following OC is consistent
with T2*-weighted signal change reflecting differences either in
penumbral oxygen consumption or vasculature response to OC
compared with surrounding tissue (10,11,25,26). Earlier valida-
tion studies with single time-point T2*OC also confirmed that
the region of increased T2* signal exhibited characteristics of
penumbra, that is, hypoperfused tissue with ongoing glucose
metabolism (25) and recovery after early reperfusion (26).
As expected, a measureable volume of penumbra was detected
with all four analysis methods at one-hour post-stroke and
decreased in size with time, as tissue became incorporated into the
ischemic core. Because a significant volume of penumbra was
detected using all four methods at four-hour post-stroke, the OCs
per se may have supported penumbra tissue and attenuated ADC-
lesion growth during the scanning session. In previous studies
using this rat strain and stroke model, where no OCs were
applied, less than 10 mm3 of mismatch remained by three to
four-hours post-stroke. There is evidence in the literature
supporting the potential of oxygen to prevent penumbra loss. In a
published study where PaO2 was maintained at 235–240 mmHg,
no deterioration in mismatch volume was apparent over the first
four-hours post-stroke (27). Studies investigating normobaric
hyperoxia have reported 100% O2 attenuated ADC lesion growth
without altering CBF, thereby preserving CBF/ADC mismatch,
and reducing infarct volume in permanent and transient MCAO
models (28–30).
Limitations and further improvements
This pilot study was not designed to establish the superiority of
one method over another, but to explore the relationship between
T2*OC responsiveness and blood flow in the evolving stroke
lesion: as such, it was not powered to detect statistical differences
between techniques. The data demonstrate a trend to improved
prediction of final infarct volume by T2*OC combined with per-
fusion imaging, which needs to be confirmed in a larger study.
The potential for translation of T2*OC as a clinical imaging
method has been established (11). A new clinical study is under
way to optimize the T2*OC technique on scanners of different
field strength, using healthy volunteers, a controlled human
model system of brain hypoperfusion, and a homogeneous clini-
cal population with acute stroke. Further refinements of the tech-
nique include strategies to increase the T2* signal to OC and
reduce the % oxygen delivered (12) which will be translated to the
clinic in the future.
Finally, improvements in penumbra detection may be possible
with susceptibility-weighted imaging. These sequences measure
magnitude information, but they also exploit phase information,
thereby producing T2*-weighted sequences which are exquisitely
sensitive to the dephasing effects of paramagnetic substances such
as deoxyhemoglobin, and provide enhanced contrast over con-
ventional gradient echo sequences.
Summary
Dual threshold T2*OC/CBF voxel-based analysis identified tissue
with characteristics of penumbra within anterior cerebral artery/
MCA collateral supply territory, which decreased in size over
time. When compared with alternative methods, T2*OC com-
bined with CBF produced the smallest error in predicting subse-
quent infarct volume. The additional information it delivers,
complementary to current MRI techniques for stroke diagnosis,
supports its potential use within the routine stroke imaging pro-
tocol and adds to evidence promoting T2*OC as a valuable
adjunct to PI/DWI imaging for penumbra detection. There was
Fig. 6 T2*OC-defined penumbra at four-hours post-stroke over eight
coronal slices with accompanying ADC maps, and 24 h RARE T2 scans
from a representative rat. Calibration bar on T2* maps, in units of per-
centage signal change and on ADC maps, in ×10−3 mm2/s. ADC, apparent
diffusion coefficient; OC, oxygen challenge.
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some evidence that repeat OCs delayed the evolution of stroke-
induced damage, but more prolonged normobaric hyperoxia and
strategies (e.g. intravenous oxygen carriers) to improve oxygen
delivery to penumbra are required to influence final outcome.
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